Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
LCMT2 Antibody
NCTP09457
Description: Rabbit polyclonal to human LCMT2
Application: ELISA, WB
Reactivity: Human
Catalog #: NCTP09457
$360.00
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human. Predicted: Rat, Mouse. |
| Isotype | IgG |
| Immunogen | Recombinant fragment corresponding to 302-462aa of human LCMT2. |
| Accession # | O60294 |
| Alternative Names | PPM2; TYW4; tRNA wybutosine-synthesizing protein 4; tRNA yW-synthesizing protein 4; Leucine carboxyl methyltransferase 2; tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase; KIAA0547; |
| Purification | Purified by antigen affinity column. |
| Formulation | Lyophilized power with 2% BSA and 0.02% NaN3 |
| Size | 100µg/200µl |
| APPLICATION | |
| ELISA | 1:10,000 – 1:100,000 |
| Western Blot | 1:200 – 1:2,000 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Jeon BN, Kim MK, Choi WI. et al. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A. Cancer Res. 72(5):1137-48 (2012). |